BackStevanato Group Spa Overview

Stevanato Group Spa Total Current Liabilities

Stevanato Group Spa's total current liabilities is $560M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$560.27M
20.94% YoYΔ $97.01M vs prior year quarter

Peer average

Loading

Stevanato Group Spa Total Current Liabilities History

Loading

Stevanato Group Spa vs. peers: Total Current Liabilities Comparison

Loading

Stevanato Group Spa Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Stevanato Group Spa (STVN) FAQ

Stevanato Group Spa's total current liabilities stands at $560M as of March 2026. That compares with $460M in the prior-year period — up 20.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Stevanato Group Spa reported $560M in total current liabilities versus $460M a year earlier — a 20.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $460M in the prior-year period — up 20.9% year over year. Sustained growth in total current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Stevanato Group Spa's total current liabilities evolved across reporting periods, while the comparison chart places STVN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total current liabilities is commonly used to spot outliers. Stevanato Group Spa's reading of $560M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.